AB Science SA
PAR:AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AB Science SA
PAR:AB
|
FR |
Multiples-Based Value
The
Multiples-Based Value for
AB Science SA (AB)
under the Base Case is
0.058
EUR.
Compared with the current market price of 1.056 EUR, the stock appears
Overvalued by 95%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AB Competitors Multiples
AB Science SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
AB Science SA
PAR:AB
|
69.9m EUR | 68 | -8.2 | -18.7 | -16 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.9B USD | 12.6 | 36 | 26.1 | 27.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.1B USD | 5.7 | 26 | 16.7 | 21.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.2 | 20.1 | 11.9 | 13.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP | 4.7 | 27.4 | 14.9 | 20.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF | 5 | 20.7 | 13.4 | 17.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.6B USD | 4.2 | 31.1 | 13.7 | 18.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 4 | 12.1 | 8.8 | 10.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
149.7B USD | 2.4 | 19.3 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.9B USD | 407.7 | 4 516.9 | 16.3 | 16.5 |